FOAMIX PHARMACEUTICALS LTD. Chart calendar Foamix Pharmaceuticals Ltd.
3ebf8d4e8.qCgZiGS_tEwWuPp6luHOeaZXI7--3HXjiDABW5wzfqE.6Ut8-gfQ_xhUlYxDxNS9L9NjYuCJkEGqunpraa0GJMzfY0jKL87gen2BjQ~f17dd8ff3d64e6dc7018e982efe5b01b
Upcoming events on Foamix Pharmaceuticals Ltd.
Past events on Foamix Pharmaceuticals Ltd.
| 2024-07-08 | Leerink Partners Therapeutics I&I and Metabolism Forum |
| 2024-05-18 11:00 am | Society for Investigative Dermatology Meeting |
| 2024-05-16 06:00 pm | Society for Investigative Dermatology Meeting |
| 2024-05-09 08:00 am | Q1 2024 Earnings Release |
| 2024-03-28 08:30 am | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 2024-03-07 12:06 pm | Global Vitiligo Foundation Scientific Symposium |
| 2024-03-04 10:30 am | TD Cowen Health Care Conference |
| 2024-02-29 08:00 am | Q4 2023 Earnings Release |
| 2023-12-13 10:00 am | Annual General Meeting |
| 2023-11-13 07:45 am | Q3 2023 Earnings Release |
| 2023-11-09 01:30 pm | R&D Day |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 08:00 am | Q2 2023 Earnings Release |
| 2023-06-04 | BIO International Convention |
| 2023-05-11 04:01 pm | Q1 2023 Earnings Release |
| 2023-03-30 03:30 pm | H.C. Wainwright Autoimmune & Inflammatory Disease Conference |
| 2023-03-09 04:01 pm | Q4 2022 Earnings Release |
| 2023-03-07 02:10 pm | Cowen Health Care Conference |
| 2023-01-12 10:00 am | Extraordinary Shareholders Meeting |
| 2023-01-09 | LifeSci Partners Corporate Access Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,44 2,34 -81.04% | 21,0 21,7 -3.3% | 14,8 17,3 -14.51% | 0,48 0,37 30.09% | 0,42 0,50 -15.2% | 0,40 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -29,3 -29,7 1.49% | -35,0 |
|
EBIT Million USD | Released Forecast Spread | -95,9 -99,9 3.98% | -253 -190 -32.84% | -68,0 -65,9 -3.17% | -34,3 -36,6 6.17% | -29,3 -32,2 9% | -35,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -95,4 -99,3 3.97% | -256 -259 1.04% | -73,8 -72,2 -2.26% | -33,9 -30,3 -12.17% | -27,9 -28,7 2.89% | -32,2 |
|
Net income Million USD | Released Forecast Spread | -95,2 -99,3 4.15% | -256 -258 1.03% | -73,3 -72,2 -1.63% | -23,2 -23,8 2.27% | -28,5 -28,7 0.86% | -32,2 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -142 -121 -17.32% | -25,6 -24,7 -3.4% | -7,28 -8,52 14.55% | -2,78 -4,82 42.32% | -0,81 |
| Announcement Date | 12/03/20 | 04/03/21 | 17/03/22 | 09/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,18 0,37 -51.45% | 0,13 0,10 26% | 0,17 0,05 234% | 0,01 0,06 -90% | 0,10 0,00 - | 0,14 0,05 170% | 0,11 0,15 -24% | 0,08 0,15 -49.33% | 0,10 0,10 -2% | 0,11 | 0,11 | 0,13 |
|
EBITDA Million USD | Released Forecast Spread | -10,8 | -6,83 -7,30 6.41% | -7,38 -8,10 8.89% | -8,50 | -8,90 | -10,2 | ||||||
|
EBIT Million USD | Released Forecast Spread | -8,69 -8,67 -0.28% | -8,29 -9,77 15.15% | -9,33 -10,3 8.95% | -7,98 -10,3 22.49% | -5,88 -8,45 30.47% | -10,3 -10,6 2.66% | ||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,69 -8,90 2.31% | -8,24 -10,3 20.05% | -9,26 -8,90 -3.99% | -7,75 -10,6 26.56% | -5,61 -8,40 33.19% | -10,0 -8,70 -15.38% | -6,07 -10,6 42.73% | -6,15 -7,00 12.11% | -8,10 | -8,30 | -9,60 | |
|
Net income Million USD | Released Forecast Spread | 4,67 -8,90 152.47% | -8,48 -10,3 17.71% | -9,46 -8,90 -6.28% | -9,95 -10,6 5.73% | -5,62 -8,40 33.07% | -10,1 -8,70 -15.61% | -6,58 -10,6 37.89% | -6,19 -7,00 11.6% | -6,25 | -8,10 | -8,30 | -9,60 |
|
EPS USD | Released Forecast Spread | 1,44 -2,94 148.98% | -2,70 -3,24 16.67% | -2,88 -2,82 -2.13% | -3,33 -3,24 -2.78% | -1,74 -2,61 33.33% | -3,09 -2,58 -19.77% | -2,01 -0,76 -164.47% | -0,20 -0,50 60% | -0,15 | -0,19 | -0,21 | -0,23 |
| Announcement Date | 12/05/22 | 12/08/22 | 10/11/22 | 09/03/23 | 11/05/23 | 14/08/23 | 13/11/23 | 29/02/24 | 09/05/24 | - | - | - |
More events
Past sector events for Foamix Pharmaceuticals Ltd.
| 2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
| 2024-07-08 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-07-07 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
| 2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
| 2024-06-06 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-06-06 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
